×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
Trinity Life Sciences introduces new customer engagement solutions, leveraging its deep commercial insight and renowned technology platform
Mercury Bio's new project includes Los Alamos and the National Center for Genome Resources.
23 Jul 2024
Mercury Bio a New Mexico-based biotech company focused on the development of a novel new
...
The merger with NLS Pharmaceutics was approved by Kadimastem shareholders
Leqembi Secures Approval for Alzheimer's Disease Treatment in Hong Kong
Vector Laboratories Appoints Ashley Scholz as Vice President of Marketing
Cognito Therapeutics Announces $105 Million Oversubscribed Series C Financing to Advance Spectris™ in Alzheimer’s Disease.
Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection in two single-dose vial strengths
By
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals
30 Jul 2026
EMS and BD expand access to GLP-1 therapies in Brazil by launching semaglutide.
By
BD (Becton, Dickinson and Company)
BD (Becton, Dickinson and Company)
29 Jul 2026
Excedr Secures $25 Million in Growth Capital to Expand Its Life Sciences Equipment Leasing Platform
By
Excedr
Excedr
28 Jul 2026
InstaMed® Pharmaceuticals Appoints Tracy Gibbs, PhD, as Chief Executive Officer Ahead of the Worldwide Launch of Its Non-Injectable Peptide Platform
By
InstaMed® Pharmaceuticals
InstaMed® Pharmaceuticals
28 Jul 2026
FDA Clears Roche's cobas® BV/CV Assay, Enabling Fast and Highly Accurate Diagnosis of Vaginitis
By
Roche
Roche
27 Jul 2026
China Approves Haisco's Class 1 Innovative Drug, Ciprocopan Succinate Tablets, Providing a New Treatment Option for Patients with PNH
By
Haisco Pharmaceutical Group Co., Ltd.
Haisco Pharmaceutical Group Co., Ltd.
24 Jul 2026
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time
By
Bloomage
Sep 12
New Study Suggests 5-MTHF as Effective Alternative to Folic Acid in Later Pregnancy
By
Ritual
May 07
Eisai strengthens its presence in Saudi Arabia by establishing a new pharmaceutical sales subsidiary to enhance its operations in the region
By
Eisai
Oct 09
July
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe to Our Monthly Newsletter
Subscribe to Pharmaceutical Era’s monthly newsletter,
Pharmaceutical Leaders Digest
®, to receive timely updates from across the pharmaceutical industry.
I agree with the
Terms and conditions
×
and the
Privacy policy
×
Please enable the javascript to submit this form
Subscribe
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand